Effects of cyclophosphamide on murine candidiasis.

Infection and Immunity
S A Moser, J E Domer

Abstract

Male CBA/J mice were given a single dose of 200 mg of cyclophosphamide (CY) per kg 3 days before a first or second cutaneous inoculation with viable Candida albicans in an attempt to suppress antibody formation and determine the effects of such suppression on the development of acquired immunity. After cutaneous inoculation, mice not treated with CY developed acquired immunity to intravenous challenge, which was accompanied by the development of circulating antibodies, delayed hypersensitivity, and in vitro responsiveness of lymph node cells to Candida antigens. CY treatment resulted in an immediate depression of peripheral blood leukocytes, with polymorphonuclear leukocytes and monocytes rebounding quickly to normal or above normal levels while lymphocyte remained depressed throughout the 4-week observation period. In vitro stimulation of lymph node cells from CY-treated mice was depressed shortly after treatment; however, responses to phytohemagglutinin and three Candida antigens (a cell wall preparation, a membrane preparation, and soluble cytoplasmic substances) recovered, whereas the responses to lipopolysaccharide did not. CY effects on the cutaneous lesion were twofold; first, the number of viable Candida cells in the le...Continue Reading

References

Jan 1, 1975·Advances in Immunology·A J Crowle
Aug 1, 1977·The Journal of Clinical Investigation·R A Joyce, P A Chervenick
Apr 1, 1978·Infection and Immunity·J E Domer, S A Moser
Jan 1, 1976·International Archives of Allergy and Applied Immunology·H SnippeJ M Willers
Jun 1, 1974·The Journal of Experimental Medicine·P H LagrangeT E Miller
Jan 1, 1974·International Archives of Allergy and Applied Immunology·F Dumont
Mar 1, 1973·Cellular Immunology·H ValdimarssonP J Holt
Mar 1, 1974·Annals of Internal Medicine·C H Kirkpatrick, T K Smith
Jun 1, 1971·Annals of Internal Medicine·C H KirkpatrickJ E Bennett
Jan 1, 1971·International Archives of Allergy and Applied Immunology·J Marbrook, B C Baguley
Oct 1, 1971·American Journal of Clinical Pathology·M A GordonJ W Fenton
Jun 1, 1967·Journal of Bacteriology·A Restrepo-Moreno, J D Schneidau
Jan 1, 1953·Biochimica Et Biophysica Acta·J A COHEN, M G P J WARRINGA
Dec 1, 1958·Journal of Chronic Diseases·S J CUTLER, F EDERER

❮ Previous
Next ❯

Citations

May 1, 1989·Mycopathologia·M E Bibas Bonet de JorratG Perdigón
Jan 1, 1988·Immunology and Cell Biology·R B Ashman, J M Papadimitriou
Oct 1, 1986·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·F L LyonJ E Domer
Jan 1, 1994·Biotherapy·B J Kullberg, J W van 't Wout
Jan 1, 1988·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·F BistoniA Cassone
Jan 18, 2002·Antimicrobial Agents and Chemotherapy·Ryogo HayashiKenji Okonogi
Nov 1, 1989·Revista Do Instituto De Medicina Tropical De São Paulo·M C RemesarM R Nejamkis
Sep 14, 2002·Infection and Immunity·Karen L WozniakPaul L Fidel
Nov 1, 1991·Antimicrobial Agents and Chemotherapy·M KakushimaT Oki
Nov 1, 1995·Infection and Immunity·A Casadevall
Apr 1, 1990·Infection and Immunity·M T Cantorna, E Balish
Jul 1, 1983·Infection and Immunity·G E Winterrowd, J E Cutler
Jun 1, 1983·Infection and Immunity·J E DomerJ W Murphy
Mar 1, 1981·Infection and Immunity·J E Cutler, A H Poor
May 1, 1982·Infection and Immunity·F BistoniE Garaci
Dec 1, 1982·Infection and Immunity·R F HectorE W Carrow
Sep 1, 1996·Antimicrobial Agents and Chemotherapy·G SamonisG P Bodey
Dec 1, 1984·Clinical Immunology and Immunopathology·E W CarrowJ E Domer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.